Leaving UL Solutions website
Within UL Solutions we provide a broad portfolio of offerings to all the medical device industries. This includes certification, Approved/Notified Body and consultancy services. In order to protect and prevent any conflict of interest, perception of conflict of interest and protection of both our brand and our customers brand, we have processes in place to identify and manage any potential conflicts of interest and maintain impartiality. UL Solutions is unable to provide consultancy services to EU MDD, MDR or IVDD Notified Body, UKCA MD Approved Body or MDSAP Customers.
  • Feature Story

OEHHA’s Intent to List Unrefined Rapeseed Oil as Carcinogen

Contact UL

December 18, 2013

The Office of Environmental Health Hazard Assessment (OEHHA) has released its intent to list emissions from high-temperature unrefined rapeseed oil as a carcinogen under the Safe Drinking Water and Toxic Enforcement Act of 1986.

A chemical must be listed under the Proposition 65 regulations when two of the following conditions are met:

  • An authoritative body formally identifies the chemical as causing cancer [Section 25306(d)].
  • The evidence considered by the authoritative body meets the sufficiency criteria contained in the regulations [Section 25306(e)].

Source